CUE
CUE
US22978P2056
Cue Biopharma, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
200.93M EUR
165.04M EUR
22.46M EUR
29.47M EUR
Enterprise Value
147.88M EUR
150.72M EUR
9.52M EUR
6.53M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-57.63x
--
--
--
Price to Sales
5.34x
4.38x
0.69x
1.09x
Price to Book
62.58x
71.45x
1.04x
1.11x
EV/Revenue
3.93x
4x
0.29x
0.24x
EV/EBITDA
-1.52x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-16.64%
-30.4%
-109.54%
-45.95%
ende